Emancipation Management’s Graham Corp GHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1.13M Sell
51,780
-25,100
-33% -$542K 5.06% 5
2019
Q3
$1.53M Sell
76,880
-3,500
-4% -$68.5K 5.41% 3
2019
Q2
$1.62M Sell
80,380
-8,300
-9% -$170K 5.58% 4
2019
Q1
$1.74M Buy
88,680
+4,300
+5% +$95.3K 4.51% 5
2018
Q4
$1.93M Sell
84,380
-1,600
-2% -$39.5K 6.86% 4
2018
Q3
$2.42M Sell
85,980
-12,700
-13% -$343K 6.05% 5
2018
Q2
$2.55M Buy
98,680
+5,800
+6% +$139K 5.34% 7
2018
Q1
$1.99M Buy
92,880
+39,130
+73% +$839K 3.52% 7
2017
Q4
$1.13M Buy
+53,750
New +$1.09M 1.89% 17
2016
Q4
Sell
-66,648
Closed -$1.27M 44
2016
Q3
$1.27M Sell
66,648
-10,219
-13% -$193K 1.96% 16
2016
Q2
$1.42M Sell
76,867
-5,300
-6% -$97.8K 1.73% 18
2016
Q1
$1.64M Buy
82,167
+20,132
+32% +$353K 2.14% 12
2015
Q4
$1.02M Buy
62,035
+1,000
+2% +$17.5K 0.96% 21
2015
Q3
$1.08M Buy
+61,035
New +$1.11M 1.01% 21

Other funds holding GHM

Emancipation Management's GHM Position: Q4 2019 in Review

Emancipation Management reduced its Graham Corp (GHM) stake by 33% in Q4 2019, selling an estimated $542K and leaving 51,780 shares worth $1.13M. The position accounts for 5.06% of the portfolio, ranked #5.

Emancipation Management first reported a position in GHM in Q3 2015 and has held it in 14 quarters since. The position peaked at $2.55M in Q2 2018. 90 funds tracked by Wall St. Rank hold GHM as of Q4 2019.

  • Emancipation Management held 51,780 shares of Graham Corp worth $1.13M as of Q4 2019.
  • Emancipation Management sold 25,100 Graham Corp shares in Q4 2019, an estimated $542K.
  • Graham Corp made up 5.06% of Emancipation Management's portfolio in Q4 2019, its #5 holding.
  • Emancipation Management first reported a position in Graham Corp in Q3 2015 and has held it in 14 quarters since.
  • Emancipation Management's Graham Corp position peaked at $2.55M in Q2 2018.
  • 90 funds tracked by Wall St. Rank held Graham Corp as of Q4 2019.

Based on Emancipation Management's 13F filing for Q4 2019, filed 10 Feb 2020.